Skip to content

Clinical trials

Phase 3 Brain Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 3 Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20152
20163
20182
20191
20201
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed4
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University6
Chinese Academy of Medical Sciences2
AbbVie1
Betta Pharmaceuticals Co., Ltd.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Guangdong Association of Clinical Trials1
NovoCure GmbH1
Yi-Long Wu1
Zhejiang Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms15
Carcinoma, Non-Small-Cell Lung7
Small Cell Lung Carcinoma2
Adenocarcinoma of Lung1
Breast Neoplasms1
Cognitive Dysfunction1
Gangliosidoses1
Gangliosidosis, GM11
Glioblastoma1
Gliosarcoma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.